Deciphering the Link Between Hyperhomocysteinemia and Ceramide Metabolism in Alzheimer-Type Neurodegeneration

Aging is one of the strongest risk factor for Alzheimer's disease (AD). However, several data suggest that dyslipidemia can either contribute or serve as co-factors in AD appearance. AD could be examined as a metabolic disorder mediated by peripheral insulin resistance. Insulin resistance is as...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Stunff, Hervé, Véret, Julien, Kassis, Nadim, Denom, Jessica, Meneyrol, Kelly, Paul, Jean-Louis, Cruciani-Guglielmacci, Céline, Magnan, Christophe, Janel, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684947/
https://www.ncbi.nlm.nih.gov/pubmed/31417486
http://dx.doi.org/10.3389/fneur.2019.00807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684947/
https://www.ncbi.nlm.nih.gov/pubmed/31417486
http://dx.doi.org/10.3389/fneur.2019.00807

Ejemplares similares